
Tirzepatide vs. Semaglutide: Which Weight Loss Injection Works Better in 2025?
Share
In recent years, the weight loss world has been revolutionized by two powerful injectable medications: Tirzepatide (brand name Mounjaro, soon Vefora in the Philippines) and Semaglutide (popularly known as Ozempic or Wegovy). Originally developed to treat type 2 diabetes, both medications have gained widespread attention for their dramatic weight loss effects—often outpacing traditional diet and exercise alone.
But with both making headlines, the question remains:
Which is better—Tirzepatide or Semaglutide?
Let’s dive deep into their differences, similarities, benefits, and side-by-side results.
1. What Are Tirzepatide and Semaglutide?
Tirzepatide is a dual-action injectable medication that mimics two hormones: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).
Semaglutide, on the other hand, targets only GLP-1.
👉 Key Difference: Tirzepatide works on two pathways for appetite control and insulin regulation. Semaglutide works on one.
2. How They Promote Weight Loss
Both drugs work by:
- Reducing appetite
- Slowing stomach emptying
- Improving insulin sensitivity
- Regulating blood sugar levels
But studies show Tirzepatide may reduce body weight more effectively than Semaglutide due to its dual-hormone mechanism.
📊 Clinical Trial Snapshot:
- Tirzepatide (15mg): Average weight loss of 22.5% of body weight over 72 weeks
- Semaglutide (2.4mg): Average weight loss of 14.9% over the same period
3. Side Effects: Are They Safe?
Both medications may cause temporary gastrointestinal side effects:
- Nausea
- Vomiting
- Diarrhea
- Constipation
These usually subside after a few weeks.
Tirzepatide may have a slightly higher incidence of nausea, but patient tolerance varies.
Good to Know: Starting at lower doses and increasing slowly minimizes side effects.
4. Dosage & Administration
- Tirzepatide: Once-weekly injection (2.5mg to 15mg)
- Semaglutide: Once-weekly injection (starting at 0.25mg, up to 2.4mg for weight loss)
💉 Ease of Use: Both are self-injected once a week via a prefilled pen.
5. Cost & Accessibility
In the Philippines and globally, price is a key consideration:
- Semaglutide (Ozempic/Wegovy): Widely available but expensive
- Tirzepatide (Mounjaro): Gaining traction, possibly more cost-effective per % of weight loss
- Local brands (like us, Vefora™) a very affordable alternative for Filipinos
Final Verdict: Tirzepatide vs. Semaglutide
Feature | Tirzepatide | Semaglutide |
---|---|---|
Targets | GLP-1 + GIP | GLP-1 only |
Average Weight Loss | ⭐ Higher (22.5%) | Lower (14.9%) |
Side Effects | Slightly more nausea | Milder GI symptoms |
Price | Competitive | High but dropping |
Availability | With Vefora™ | More established |
🏆 Winner: Tirzepatide
Still, the choice depends on your goals, budget, and how your body responds.